Evidence map›Paper›PMID 36267566›Full record

ArticleFrontiers in endocrinology2022

MiR-539-3p impairs osteogenesis by suppressing Wnt interaction with LRP-6 co-receptor and subsequent inhibition of Akap-3 signaling pathway.

Alok Tripathi, Aijaz A John, Deepak Kumar, Saurabh Kumar Kaushal, Devendra Pratap Singh, Nazim Husain, Jayanta Sarkar, Divya Singh

Open access · goldAbstract read
In one paragraph

Article in Frontiers in endocrinology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.1field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Alok TripathiDivision of Endocrinology, Council of Scientific and Industrial Research-Central Drug Research Institute, Lucknow, India.
Aijaz A JohnDivision of Endocrinology, Council of Scientific and Industrial Research-Central Drug Research Institute, Lucknow, India.
Deepak KumarAcademy of Scientific and Innovative Research (AcSIR) Ghaziabad, Uttar Pradesh, India.
Saurabh Kumar KaushalDivision of Endocrinology, Council of Scientific and Industrial Research-Central Drug Research Institute, Lucknow, India.
Devendra Pratap SinghDivision of Endocrinology, Council of Scientific and Industrial Research-Central Drug Research Institute, Lucknow, India.
Nazim HusainDivision of Endocrinology, Council of Scientific and Industrial Research-Central Drug Research Institute, Lucknow, India.
Jayanta SarkarAcademy of Scientific and Innovative Research (AcSIR) Ghaziabad, Uttar Pradesh, India.
Divya SinghDivision of Endocrinology, Council of Scientific and Industrial Research-Central Drug Research Institute, Lucknow, India.
Central Drug Research Institute · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

X-linked hypophosphatemia (XLH), an inheritable form of rickets is caused due to mutation in Phex gene. Several factors are linked to the disease's aetiology, including non-coding RNA molecules (miRNAs), which are key post-transcriptional regulators of gene expression and play a significant role in osteoblast functions. MicroRNAs sequence analysis showed differentially regulated miRNAs in phex silenced osteoblast cells. In this article, we report miR-539-3p, an unidentified novel miRNA, in the functional regulation of osteoblast. MiR-539-3p overexpression impaired osteoblast differentiation. Target prediction algorithm and experimental confirmation by luciferase 3' UTR reporter assay identified LRP-6 as a direct target of miR-539-3p. Over expression of miR-539-3p in osteoblasts down regulated Wnt/beta catenin signaling components and deteriorated trabecular microarchitecture leading to decreased bone formation in ovariectomized (Ovx) mice. Additionally, biochemical bone resorption markers like CTx and Trap-5b were elevated in serum samples of mimic treated group, while, reverse effect was observed in anti-miR treated animals along with increased bone formation marker P1NP. Moreover, transcriptome analysis with miR-539-3p identified a novel uncharacterized Akap-3 gene in osteoblast cells, knock down of which resulted in downregulation of osteoblast differentiation markers at both transcriptional and translational level. Overall, our study for the first time reported the role of miR-539-3p in osteoblast functions and its downstream Akap-3 signalling in regulation of osteoblastogenesis.

Indexed as

A Kinase Anchor ProteinsLow Density Lipoprotein Receptor-Related Protein-6MicroRNAsOsteogenesis3' Untranslated RegionsAnimalsAntagomirsbeta CateninMiceWnt Signaling Pathway3' Untranslated RegionsAkap3 protein, mouseA Kinase Anchor ProteinsAntagomirsbeta CateninLow Density Lipoprotein Receptor-Related Protein-6Lrp6 protein, mouseMicroRNAsMIRN539 microRNA, mouseAKAP-3LRP-6microRNAPHEXX-linked hypophosphatemia

Identifiers

PMID36267566
PMCPMC9577939
OpenAlexW4297997229

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.